Brief: Chinook Therapeutics Announces The Appointment Of Andrew Oxtoby As Chief Commercial Officer
15/02/2023 13:52
Feb 15 (Reuters) - Chinook Therapeutics Inc KDNY.O :
* CHINOOK THERAPEUTICS ANNOUNCES THE APPOINTMENT OF ANDREW
OXTOBY
AS CHIEF COMMERCIAL OFFICER
Source text for Eikon: ID:nGNX7Dmb47
Further company coverage: KDNY.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Chinook Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Chinook Therapeutics
Chinook Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Chinook Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
Brief: Chinook Therapeutics Announces First Patient Enrolled In Phase 3 Of Zigakibart
Brief: Muddy Waters- Remains Short On Chinook Therapeutics Inc